ARC
Advisor Resource Council’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,217
| Closed | -$423K | – | 592 |
|
|
2025
Q1 | $423K | Buy |
+5,217
| New | +$423K | 0.03% | 392 |
|
|
2024
Q4 | – | Sell |
-2,628
| Closed | -$260K | – | 266 |
|
|
2024
Q3 | $260K | Buy |
+2,628
| New | +$260K | 0.12% | 186 |
|
|
2024
Q1 | – | Sell |
-5,241
| Closed | -$468K | – | 534 |
|
|
2023
Q4 | $468K | Buy |
+5,241
| New | +$468K | 0.05% | 275 |
|
|
2022
Q3 | – | Sell |
-8,395
| Closed | -$624K | – | 512 |
|
|
2022
Q2 | $624K | Buy |
+8,395
| New | +$624K | 0.06% | 256 |
|
|
2022
Q1 | – | Sell |
-21,503
| Closed | -$2.41M | – | 562 |
|
|
2021
Q4 | $2.41M | Buy |
+21,503
| New | +$2.41M | 0.19% | 113 |
|